Fine-Mapping the MHC in Multiple Sclerosis: HLA and Non-HLA Genetic Risk Signals
The article “Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects” investigates one of the most important genomic regions in multiple sclerosis (MS): the major histocompatibility complex (MHC) on chromosome 6. This region has long been recognized as the strongest genetic contributor to MS susceptibility, particularly through the HLA-DRB1*15:01 allele. The study aimed to move beyond broad association signals and identify statistically independent genetic effects within the MHC by analyzing SNPs, classical HLA alleles, and amino acid polymorphisms in 5,091 MS cases and 9,595 controls.
A High-Resolution Strategy for HLA Fine-Mapping
A major strength of the study lies in its use of imputation to infer classical HLA alleles and amino acid variation from genome-wide association study data. The authors analyzed eight classical HLA genes, including class I genes such as HLA-A, HLA-B, and HLA-C, and class II genes such as HLA-DRB1, HLA-DQB1, HLA-DQA1, HLA-DPB1, and HLA-DPA1. This strategy enabled the researchers to test thousands of variants across a highly complex linkage disequilibrium region, where nearby variants are often inherited together and therefore difficult to separate statistically.
HLA-DRB1 Remains the Dominant MS Susceptibility Locus
The most important finding was the confirmation that HLA-DRB115:01 is the strongest genetic risk factor for MS, with an odds ratio of approximately 2.92. The authors also showed that the association previously attributed to neighboring DQB1 or DQA1 variants could be largely explained by DRB115:01 itself. Importantly, the DRB1 locus was not defined by a single allele: five additional independent DRB1 effects were detected, namely DRB103:01, DRB113:03, DRB104:04, DRB104:01, and DRB1*14:01. Together, these results support a multi-allelic model in which several DRB1 variants contribute independently to MS susceptibility.
Protective and Risk Effects Beyond DRB1
After controlling for the six independent DRB1 effects, the authors identified additional associations across the MHC. HLA-A*02:01 showed an independent protective effect, reducing MS risk, and this signal was statistically equivalent to an amino acid polymorphism at position 95 in the HLA-A peptide-binding groove. The study also identified an HLA-DPB1-associated effect, best represented by rs9277489 or by leucine at amino acid position 65 in HLA-DPβ1. These findings reinforce the idea that MS risk is shaped by both class I and class II antigen-presentation pathways, rather than by HLA-DRB1 alone.
Evidence for a Non-HLA Signal Within the MHC
One of the most notable contributions of the study was the discovery of a statistically independent non-classical MHC association spanning the MICB-LST1 region. This region does not contain classical HLA class I or class II genes but includes biologically relevant immune genes such as MICB, DDX39B, NFKBIL1, TNF, LTA, LTB, and LST1. The association became evident only after adjustment for the strong DRB1*15:01 effect, illustrating how dominant signals can obscure weaker but genuine associations. The presence of TNF in this region is particularly intriguing because TNF-related pathways have already been implicated in MS genetics through TNFRSF1A.
Structural Clues from Amino Acid Variation
The article also connects statistical genetics with protein structure. Several associated amino acid residues were located in peptide-binding grooves of HLA molecules, including positions in HLA-DRβ1, HLA-A, HLA-DPβ1, and HLA-B. The figure on page 4 illustrates three-dimensional HLA protein models and highlights these residues within peptide-binding regions, supporting the hypothesis that altered antigen presentation may influence MS susceptibility. For HLA-DRβ1, four amino acid positions—71, 74, 57, and 86—captured much, though not all, of the DRB1 association, suggesting that MS risk may arise from complex structural changes affecting peptide binding and T-cell recognition.
Scientific Significance and Future Directions
Overall, the study identified 11 statistically independent MHC effects: six HLA-DRB1 alleles, one HLA-DPB1 effect, one HLA-A effect, two HLA-B effects, and one non-HLA signal in the MICB-LST1 region. These effects collectively explained approximately 14.2% of the phenotypic variance in MS susceptibility, with HLA-DRB1*15:01 alone explaining about 10%. The work provides a refined genetic map of MS risk within the MHC and establishes a framework for future functional studies. Its central message is that MS susceptibility is not governed by a single HLA allele, but by a layered architecture of classical HLA alleles, amino acid changes affecting antigen presentation, and non-HLA immune regulatory signals.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Patsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., Van Duijn, C. M., Noble, J. A., ... & de Bakker, P. I. (2013). Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS genetics, 9(11), e1003926.
